Omnia Medical

What Omnia Medical does

Omnia Medical, LLC is a privately held orthopedic implant company founded in 2013 and headquartered in Morgantown, West Virginia. The company develops and commercializes a portfolio of spinal and sacroiliac (SI) joint products, including SI joint stabilization systems (PsiF, PsiF90, PsiF DNA, PsiFGuard), interbody fusion devices for cervical and lumbar procedures (Rotary, TiBrid C, TiBrid SA), a PEEK-OPTIMA HA Enhanced vertebral body replacement system (Boxcar), and bone graft biologics (CeLLogix, DBLogix). The company serves spine surgeons, orthopedic surgeons, and interventional pain physicians practicing in hospitals and ambulatory surgical centers (ASCs), with a particular emphasis on minimally invasive and outpatient-compatible procedures.

The company's technology platform is built around proprietary materials and architectures: a Double-Helix implant design that leverages autograft bone from both the ilium and sacrum for SI joint arthrodesis; PEEK-OPTIMA HA Enhanced polymer with hydroxyapatite integrated throughout the matrix for improved bone apposition; 3D-printed porous titanium at 75% porosity and 550 micrometer diameter (used in TiBrid SA and TiBrid C devices); and a proprietary mechanical assembly process using titanium pins rather than coatings. Through its strategic alliance with SpineGuard, Omnia integrates Dynamic Surgical Guidance (DSG) technology — which measures electrical conductivity to provide real-time audible intraoperative feedback — into its PsiFGuard and PsiF DNA systems. The April 2026 SpineGuard Inc. U.S. asset transfer added exclusive U.S. distribution rights for PediGuid pedicle screw devices, extending Omnia's footprint into surgical guidance hardware without organic development.

Omnia generates revenue through hardware sales of implants and biologics to healthcare providers under quote-based, multi-year contract pricing. The go-to-market model combines direct sales (W2 representatives), a physician and distributor recruitment network, surgeon training programs, and conference-based demand generation. FDA 510(k) clearances underpin the portfolio (Boxcar in September 2019, PsiF DNA in May 2025), and the company has defended its IP position through the June 2025 PainTEQ settlement, in which the competitor admitted infringement of Omnia's D232 design patent and unauthorized use of the PsiF trademark. The company is privately held with no disclosed funding rounds or external investors identified.

Name

Omnia Medical

Legal name

Omnia Medical, LLC

Website

https://omniamedical.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Omnia Medical, LLC is a privately held orthopedic implant company founded in 2013 in Morgantown, WV that develops FDA-cleared sacroiliac joint fusion systems, cervical and lumbar interbody devices, vertebral body replacement, and bone graft biologics for spine surgeons, orthopedic surgeons, and interventional pain physicians practicing in hospitals and ASCs.

Ownership category

akta.pro rank

Product category

Spinal Orthopedic Implants

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

akta.pro secondary industries

3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts) (HLAHAEAD), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG), Orthopedic & Spine Surgery Centers (HLAFAIAG)

Keywords

• Spinal implants
• Sacroiliac joint fusion
• Interbody fusion devices
• Vertebral body replacement
• Bone graft biologics

Headquarters

HQ city

Morgantown

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Spinal and Orthopedic Implant Sales: Omnia Medical generates revenue through the sale of medical implants including sacroiliac joint fusion systems, interbody fusion devices, vertebral body replacement systems, and biologics products to spine surgeons, orthopedic surgeons, and interventional pain physicians.
2. Distribution Revenue: Following the April 2026 asset transfer from SpineGuard Inc., Omnia Medical now commercializes PediGuard devices in the U.S. under an exclusive distribution agreement, expanding their revenue stream to include surgical guidance devices.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

Omnia Medical designs, develops, and manufactures FDA-cleared orthopedic implants and surgical instruments for spine and sacroiliac (SI) joint procedures, including SI joint stabilization systems (PsiF family), interbody fusion devices (TiBrid C, TiBrid SA, Rotary), a vertebral body replacement (Boxcar), and bone graft biologics (CeLLogix, DBLogix). The portfolio is sold to spine surgeons, orthopedic surgeons, interventional pain physicians, hospitals, and ambulatory surgical centers (ASCs), with an emphasis on minimally invasive solutions.

Product overview

Omnia Medical is an orthopedic implant company offering a portfolio of spinal and sacroiliac joint products. The core portfolio centers on SI joint stabilization systems (PsiF, PsiF90, PsiF DNA, PsiFGuard) for treating sacroiliac joint dysfunction, complemented by interbody fusion devices (Rotary, TiBrid C, TiBrid SA) for cervical and lumbar procedures, vertebral body replacement (Boxcar), and bone graft biologics (CeLLogix, DBLogix). The PsiF family represents the flagship SI joint product line, while TiBrid devices differentiate through hybrid PEEK-OPTIMA HA Enhanced and 3D-printed porous titanium construction. The company focuses on minimally invasive solutions with surgeon-friendly instrumentation.

Differentiator

Problem solved

Functional benefit

Brands

• PsiF DNA: Sacroiliac Joint Stabilization System with double-helix architecture for SI joint fusion
• PsiF
• PsiF90
• PsiFGuard
• TiBrid SA
• TiBrid C
• Rotary
• DBLogix
• CeLLogix
• Boxcar

Products and services

• PsiF DNA™ FDA 510(k)-cleared sacroiliac (SI) joint stabilization system with double-helix architecture designed for minimally invasive posterior approach; leverages autograft bone from both ilium and sacrum to support arthrodesis and long-term joint stabilization. Targets spine surgeons and interventional pain physicians treating SI joint dysfunction.
• PsiF90 Posterior SI procedure kit for minimally invasive intra-articular SI joint stabilization featuring a novel insert-and-rotate implant design, a broach-less system that reduces patient trauma, and a dime-size incision. Targets interventional pain physicians and spine surgeons performing outpatient SI procedures.
• PsiFGuard FDA-cleared real-time guidance technology for SI joint detection using Dynamic Surgical Guidance (DSG) that measures electrical conductivity and provides audible signals (high-pitched tones for soft tissues/joint space, low-pitched tones for cortical bone) to assist precise drilling and wire placement. Integrated with the PsiF family of SI joint devices.
• PsiF Posterior SI fusion system using a one-size structural allograft implant (8x10x25mm) for minimally invasive SI joint stabilization through familiar prone patient positioning and a simple posterior approach. Targets spine surgeons and interventional pain physicians.
• Boxcar First PEEK-OPTIMA HA Enhanced vertebral body replacement system, offered in two footprints (12x12.5mm and 14x14.5mm), height range 13-75mm, with lordotic endplates for cervical corpectomy procedures. Targets spine surgeons performing cervical reconstruction.
• Rotary Rotatable interbody fusion device with a proprietary dual taper design that aids initial distraction and creates lordosis after rotation using an insert-and-rotate technique. Targets spine surgeons performing interbody fusion procedures.
• CeLLogix Allogeneic bone scaffold containing viable bone-derived cells with osteoinductive potential, featuring an optimized bone microparticulate size range of 100-300 micrometers and a minimum of 150,000 viable cells per cc post-thaw. Used as a bone graft biologic in spine fusion procedures.
• DBLogix Demineralized bone matrix putty engineered for osteoconduction, shown equivalent to iliac crest autograft in preclinical spinal fusion models, with assured osteoinductivity that resists irrigation. Targets spine and orthopedic surgeons requiring bone graft substitutes.
• TiBrid C Cervical interbody fusion device combining 3D-printed porous titanium with HA-enhanced PEEK-OPTIMA, available in three footprints (14x12mm, 16x13mm, 18x15mm) and eight height options (5-12mm). Targets spine surgeons performing cervical interbody fusion.
• TiBrid SA Standalone ALIF interbody fusion device combining PEEK-OPTIMA HA Enhanced with 3D-printed porous titanium (75% porosity, 550 micrometer diameter), featuring hydroxyapatite integrated throughout for earlier bone ongrowth. Targets spine surgeons performing anterior lumbar interbody fusion.

Quantifiable outcome

• 89.47% improvement in guidewire placement accuracy compared to traditional freehand techniques
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core.

• SpineGuardcoreChannel Partner/ Reseller/ Distributor · 13 April 2026SpineGuard transferred SpineGuard Inc. assets to Omnia Medical and entered an exclusive U.S. distribution agreement for PediGuard devices. Under the agreement, SpineGuard continues designing and manufacturing PediGuard devices while supplying them to Omnia Medical, which assumes full commercialization responsibility. The transaction is expected to reduce SpineGuard's structural costs while expanding Omnia's product portfolio.
• SpineGuardcoreStrategic or Co-development Partner · 12 September 2022Strategic alliance for adult spine surgery in the U.S. involving co-development and exclusive distribution agreement. The partnership spans two novel devices: a smart single-step pedicle screw system and a smart drilling tool for sacroiliac joint fusion, both embedding DSG technology. Both companies aim to make spine surgery safer and achieve superior surgical outcomes while reducing healthcare costs.
• Invibio Biomaterial SolutionscoreTechnology or Integration · 24 September 2019Omnia Medical developed the Boxcar VBR system using PEEK-OPTIMA HA Enhanced polymer from Invibio Biomaterial Solutions, part of Victrex plc. The Boxcar achieved the first FDA 510(k) clearance for a cervical VBR system manufactured from this material, which integrates hydroxyapatite throughout the polymer matrix for improved bone apposition.
• SpineGuardcoreTechnology or IntegrationSpineGuard's PsiF Guard technology (Dynamic Surgical Guidance) is integrated into the PsiF DNA system to provide real-time intraoperative feedback and confirmation of implant positioning. The partnership spans multiple novel devices including smart single-step pedicle screw systems and smart drilling tools for sacroiliac joint fusion.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• SI-Bone: SI-Bone is the market leader in minimally invasive SI joint fusion with the iFuse Implant System, directly competing with Omnia's PsiF/Boxcar/PsiF90 portfolio. It is the most directly comparable pure-play SI joint fusion company.
• PainTEQ: PainTEQ offers the LinQ sacroiliac joint stabilization procedure and is a direct competitor in the SI joint fusion space; it was also Omnia's primary litigation counterpart, with the parties resolving disputes in June 2025.
• Alphatec Spine: Alphatec Spine develops and markets spine fusion implants and biologics for cervical and lumbar procedures, with a product portfolio that directly overlaps Omnia's interbody fusion (TiBrid/Rotary), VBR (Boxcar), and SI joint efforts via its acquisition activity.
• Surgalign Holdings: Surgalign develops and markets spinal hardware and biologics for fusion procedures, with portfolio overlap in interbody devices and bone graft products that compete in the same surgeon channels as Omnia.

Broad incumbents

• Globus Medical: Globus Medical (now merged with NuVasive) is a broad spine implant incumbent offering interbody fusion, VBR, and biologics that overlap directly with Omnia's TiBrid, Boxcar, Rotary, DBLogix, and CeLLogix product lines.
• Orthofix Medical: Orthofix is a spine and orthopedic device company with biologics and motion preservation products, providing a comparable incumbent reference point for Omnia's spine and bone graft biologics portfolio.
• Stryker: Stryker's spine division offers broad interbody and cervical fusion implants that overlap with Omnia's TiBrid and Boxcar lines; as a large-cap incumbent, it represents the competitive ceiling Omnia faces in spine.
• Medtronic: Medtronic is the largest spine implant incumbent with broad cervical and lumbar fusion portfolios; its scale and procedural breadth set the strategic context for Omnia's spine and SI joint ambitions.
• Zimmer Biomet: Zimmer Biomet is a broad orthopedic and spine incumbent with cervical/lumbar fusion and biologics offerings that overlap with Omnia's portfolio, providing a benchmark large-cap comparable for the orthopedic implant space.

Others

• SpineGuard: SpineGuard is Omnia's strategic partner and licensor of Dynamic Surgical Guidance (DSG) technology, as well as the counterparty in the April 2026 US PediGuard asset transfer; while not a direct competitor to Omnia's implants, it is a critical enabling technology and supply partner.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/omnia-medical

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Omnia Medical